Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study

Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study

Abstract Background Long-acting injectable depot buprenorphine may increase access to opioid agonist treatment (OAT) for patients with opioid use disorder in different treatment phases. The aim of this study was to explore the experiences of depot buprenorphine among Swedish patients with ongoing su...

Full description

Bibliographic Details
Main Authors: Björn Johnson, Bodil Monwell, Andrea Johansson Capusan
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Harm Reduction Journal
Subjects:
Opioid use disorder
Treatment
Polydrug use
Psychiatric comorbidity
Long-acting injectable depot buprenorphine
Qualitative interviews.
Online Access:https://doi.org/10.1186/s12954-024-00984-1

Internet

https://doi.org/10.1186/s12954-024-00984-1

Similar Items